Search Results 1271-1280 of 20124 for Hepatitis C
noma, Hepatitis C, Hepatocellular carcinoma, Nonalcoholic fatty liver disease, Cirrhosis, Liver cancer, Gallbladder cancer, Hepatic encephalopathy, Chronic ...
HIV, hepatitis B, hepatitis C, or tuberculosis (TB) infection; Participated in a clinical study with an investigational drug or biologic within the last 30 ...
... hepatitis B (defined as HBsAg reactive), Hepatitis C (defined as hepatitis. C virus (HCV) RNA [qualitative] is detected) and/or HIV. No testing for Hepatitis B,
Other causes of liver disease (e.g., alcoholic liver disease, hepatitis B virus infection, chronic hepatitis C virus infection, autoimmune hepatitis, drug ...
Evidence of active and uncontrolled hepatitis B and/or hepatitis C. Screening for hepatitis B and hepatitis C is not required. Participants previously ...
Known hepatitis B or hepatitis C infection. Other active malignancy. Females only: Pregnant or breastfeeding. Prior stem cell transplantation. Acute ...
Known active Hepatitis B/ Hepatitis C/ HIV infection; Known, uncontrolled CNS metastases or primary CNS lymphoma; Deep vein thrombosis diagnosed within 3 ...
Positive hepatitis B (hepatitis B surface antigen and antibody) and/or hepatitis C (hepatitis C antibody test) as indicated by serologies conducted =< 3 ...
No known Hepatitis B, Hepatitis C active disease. No known Human Immunodeficiency Virus (HIV) seropositivity. The risk for potential toxicities secondary to ...
Helmers RA, Byrne TJ, Wesselius LJ, Leslie KO. Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient. Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!